Resumen de New Approved Use For Antibiotic Telavancin

Diane S. Aschenbrenner

• * The antibiotic telavancin (Vibativ) has been approved for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia caused by Staphylococcus aureus. * In clinical trials, patients taking telavancin who had moderate-to-severe renal impairment had higher all-cause mortality than renally impaired patients taking vancomycin.